Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q3 2025

Type / Class
Equity / Class A ordinary shares, par value $0.0001 per share
Symbol
TDAC on Nasdaq
Shares outstanding
17,244,009
Price per share
$10.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
15,281,948
Total reported value
$155,786,911
% of total 13F portfolios
0%
Share change
+1,322,260
Value change
+$15,103,754
Number of holders
41
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WOLVERINE ASSET MANAGEMENT LLC 9% +15% $16,069,623 +$2,089,212 1,557,134 +15% WOLVERINE ASSET MANAGEMENT LLC 30 Sep 2025
AQR CAPITAL MANAGEMENT LLC 6.4% -25% $11,087,889 -$3,880,911 1,099,989 -26% AQR Capital Management, LLC 31 Mar 2025
BANK OF MONTREAL /CAN/ 4.6% -19% $8,064,000 -$2,016,000 800,000 -20% Bank of Montreal 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.3% -58% $4,032,000 -$5,040,000 400,000 -56% Healthcare of Ontario Pension Plan Trust Fund 31 Mar 2025

As of 30 Sep 2025, 41 institutional investors reported holding 15,281,948 shares of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC). This represents 89% of the company’s total 17,244,009 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) together control 79% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WOLVERINE ASSET MANAGEMENT LLC 9% 1,557,134 +15% 0.24% $16,116,336
Magnetar Financial LLC 7.5% 1,300,000 0% 0.08% $13,461,500
AQR Arbitrage LLC 6.4% 1,096,989 -0.27% 0.29% $11,342,866
LMR Partners LLP 4.6% 800,000 0% 0.11% $8,280,000
Hudson Bay Capital Management LP 3.8% 650,000 0% 0.04% $6,727,500
First Trust Capital Management L.P. 3.8% 649,998 0% 0.43% $6,727,479
TENOR CAPITAL MANAGEMENT Co., L.P. 3.7% 635,399 0% 0.09% $6,576,380
Karpus Management, Inc. 3.6% 616,775 0% 0.2% $6,377,454
Polar Asset Management Partners Inc. 3.5% 600,000 0% 0.13% $6,210,000
Linden Advisors LP 3.5% 600,000 0% 0.04% $6,210,000
Radcliffe Capital Management, L.P. 2.9% 504,305 +188% 0.32% $5,222,078
PICTON MAHONEY ASSET MANAGEMENT 2.8% 475,002 0% 0.06% $4,918,000
GLAZER CAPITAL, LLC 2.4% 413,449 -1.8% 0.14% $4,275,000
Periscope Capital Inc. 2.3% 400,090 +100% 1% $4,142,932
RIVERNORTH CAPITAL MANAGEMENT, LLC 2.3% 400,000 0.24% $4,136,000
GOLDMAN SACHS GROUP INC 2.2% 385,010 0% 0% $3,981,003
MIZUHO SECURITIES USA LLC 2.1% 362,988 -34% 0.08% $3,735,627
MMCAP International Inc. SPC 2% 350,000 0.42% $3,622,500
D. E. Shaw & Co., Inc. 2% 346,900 0% 0% $3,590,415
WHITEBOX ADVISORS LLC 1.8% 305,000 0% 0.06% $3,156,750
Crossingbridge Advisors, LLC 1.4% 250,000 -38% 0.13% $250,000
Westchester Capital Management, LLC 1.4% 248,852 0.13% $2,573,129
Wealthspring Capital LLC 1.2% 207,230 -1.3% 0.51% $2,142,758
Governors Lane LP 1.2% 203,163 0% 0.29% $2,103,753
Verition Fund Management LLC 1.2% 201,538 0% 0.01% $2,085,918

Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 15,281,948 $155,786,911 +$15,103,754 $10.35 41
2025 Q2 13,959,688 $142,484,311 +$30,107,614 $10.27 38
2025 Q1 11,160,102 $112,476,282 +$112,476,283 $10.08 30